You are about to be taken to a third-party site. The content on this site is for informational use only. L-Nutra does not endorse any of the information, products, or services on third-party sites, and no information on third-party sites should be construed as an endorsement or recommendation of specific L-Nutra products. By clicking on the link below, you consent to be directed to external material.Proceed Cancel
The biotech division of L-Nutra, Nutritech Therapeutics is leveraging the power of the Fasting Mimicking Technology Platform to develop plant-based therapeutics that target a broad spectrum of diseases.
While most pharmaceutical companies develop drugs aimed at mitigating the last phase of an illness, Nutritech Therapeutics is pursuing a revolutionary approach centered around L-Nutra’s Fasting Mimicking Technology – an upstream intervention that has remarkable, clinically tested, downstream benefits.
Decades of research have shown how the stress of fasting triggers autophagy and causes individual cells to undergo repair. This, in turn, can optimize entire biological systems – a fact that has profound implications for treating life-threatening diseases. Applying the insights from years of studying the effects of nourished fasting, Nutritech Therapeutics is designing plant-based fasting mimetics that are specifically tailored to the unique properties of a variety of diseases.
We believe Fasting Mimicking Technology and tailored fasting mimetics are the key to unlock an exciting new chapter in medical therapies.